Neil Stahl
2012
In 2012, Neil Stahl earned a total compensation of $12M as Executive Vice President, Research & Development at Regeneron Pharmaceuticals, a 281% increase compared to previous year.
Compensation breakdown
| Bonus | $373,167 |
|---|---|
| Option Awards | $11,144,533 |
| Salary | $460,700 |
| Other | $16,800 |
| Total | $11,995,200 |
Stahl received $11.1M in option awards, accounting for 93% of the total pay in 2012.
Stahl also received $373.2K in bonus, $460.7K in salary and $16.8K in other compensation.
Rankings
In 2012, Neil Stahl's compensation ranked 293rd out of 11,487 executives tracked by ExecPay. In other words, Stahl earned more than 97.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 293 out of 11,487 | 97th |
Division Manufacturing | 110 out of 4,252 | 97th |
Major group Chemicals And Allied Products | 21 out of 1,200 | 98th |
Industry group Drugs | 12 out of 922 | 99th |
Industry Pharmaceutical Preparations | 9 out of 697 | 99th |
Source: SEC filing on April 21, 2015.
Stahl's colleagues
We found four more compensation records of executives who worked with Neil Stahl at Regeneron Pharmaceuticals in 2012.
2012
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2012
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2012
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
2012
Robert Terifay
Regeneron Pharmaceuticals